• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High-dose steroids for the treatment of severe COVID-19.

作者信息

Piccica Matteo, Lagi Filippo, Trotta Michele, Spinicci Michele, Zammarchi Lorenzo, Bartoloni Alessandro

机构信息

Department of Experimental and Clinical Medicine, SOD Malattie Infettive eTropicali, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

出版信息

Intern Emerg Med. 2021 Aug;16(5):1395-1399. doi: 10.1007/s11739-021-02707-x. Epub 2021 Apr 15.

DOI:10.1007/s11739-021-02707-x
PMID:33856664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8047517/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/8047517/21e0aa366ced/11739_2021_2707_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/8047517/21e0aa366ced/11739_2021_2707_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/8047517/21e0aa366ced/11739_2021_2707_Fig1_HTML.jpg

相似文献

1
High-dose steroids for the treatment of severe COVID-19.大剂量类固醇用于治疗重症新型冠状病毒肺炎。
Intern Emerg Med. 2021 Aug;16(5):1395-1399. doi: 10.1007/s11739-021-02707-x. Epub 2021 Apr 15.
2
Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome.脉冲式甲泼尼龙治疗特发性激素抵抗型肾病综合征
Pediatr Nephrol. 2002 Apr;17(4):299; author reply 300-1. doi: 10.1007/s00467-001-0797-7.
3
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.高剂量与标准剂量皮质类固醇治疗重症 COVID-19 的回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):761-769. doi: 10.1007/s10096-020-04078-1. Epub 2020 Oct 20.
4
[Alopecia areata and pulse methylprednisolone therapy].[斑秃与脉冲式甲泼尼龙治疗]
Ann Dermatol Venereol. 2004 Mar;131(3):286-7. doi: 10.1016/s0151-9638(04)93596-x.
5
Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone.高剂量静脉注射甲基强的松龙治疗人工晶状体眼黄斑囊样水肿
J Cataract Refract Surg. 1999 Sep;25(9):1286-8. doi: 10.1016/s0886-3350(99)00159-5.
6
[Induction therapy with corticoid pulses for treatment of temporal arteritis].[用皮质类固醇脉冲进行诱导治疗以治疗颞动脉炎]
Z Rheumatol. 2007 Mar;66(2):165-6. doi: 10.1007/s00393-007-0148-6.
7
Steroids for acute exacerbations of COPD : how long is enough?用于慢性阻塞性肺疾病急性加重期的类固醇：使用多长时间足够？
Chest. 2001 Mar;119(3):675-6. doi: 10.1378/chest.119.3.675.
8
Mega dose methylprednisolone (MDMP) treatment.大剂量甲基强的松龙（MDMP）治疗。
Turk J Pediatr. 2004 Jul-Sep;46(3):292; author reply 293.
9
High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection.大剂量类固醇用于治疗西尼罗河病毒感染所致急性弛缓性麻痹
Scand J Infect Dis. 2004;36(6-7):509-12. doi: 10.1080/00365540410020659.
10
Disseminated cutaneous mucormycosis in a patient on high-dose steroid therapy for severe ARDS.一名因严重急性呼吸窘迫综合征接受大剂量类固醇治疗的患者发生播散性皮肤毛霉病。
Intensive Care Med. 2011 Nov;37(11):1895-6. doi: 10.1007/s00134-011-2347-5. Epub 2011 Aug 20.

引用本文的文献

1
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.住院患者中发生重症 COVID-19 的预测因素：一项回顾性研究。
Front Med (Lausanne). 2025 Jan 14;11:1494302. doi: 10.3389/fmed.2024.1494302. eCollection 2024.
2
New onset diabetes mellitus in post-COVID-19 patients.新冠病毒感染康复后患者新发糖尿病
J Family Med Prim Care. 2022 Oct;11(10):5961-5968. doi: 10.4103/jfmpc.jfmpc_316_22. Epub 2022 Oct 31.
3
Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside.抗击 COVID-19 的治疗策略：从实验室到临床。

本文引用的文献

1
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
2
"COVID-19: diagnosis, management and prognosis": a new topical collection of Internal and Emergency Medicine.《“COVID-19：诊断、管理与预后”》：内科学与急诊医学新的专题文集
Intern Emerg Med. 2020 Aug;15(5):747-750. doi: 10.1007/s11739-020-02461-6. Epub 2020 Jul 30.
3
Pulmonary fibrosis secondary to COVID-19: a call to arms?
Iran J Med Sci. 2022 Nov;47(6):517-532. doi: 10.30476/IJMS.2021.92662.2396.
4
The effect of steroids used in the treatment of coronavirus disease 2019 on infections in intensive care.2019冠状病毒病治疗中使用的类固醇对重症监护病房感染的影响。
North Clin Istanb. 2022 Apr 13;9(2):131-139. doi: 10.14744/nci.2022.43827. eCollection 2022.
5
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19.等待新冠病毒病的治愈方法：针对不同严重程度新冠病毒病患者的治疗方法
Infez Med. 2022 Mar 1;30(1):11-21. doi: 10.53854/liim-3001-2. eCollection 2022.
6
Predictors of Mortality in COVID-19 Patients in Southern California - Retrospective Multicenter Study.南加州新冠病毒疾病患者死亡率的预测因素——回顾性多中心研究
Cureus. 2021 Sep 20;13(9):e18137. doi: 10.7759/cureus.18137. eCollection 2021 Sep.
7
High-dose steroids for the treatment of severe COVID-19: comment.大剂量类固醇用于治疗重症新型冠状病毒肺炎：评论
Intern Emerg Med. 2021 Aug;16(5):1415-1416. doi: 10.1007/s11739-021-02766-0. Epub 2021 May 26.
8
High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?大剂量类固醇治疗重症新型冠状病毒肺炎：一种新的治疗手段？
Intern Emerg Med. 2021 Aug;16(5):1329-1330. doi: 10.1007/s11739-021-02722-y. Epub 2021 Apr 19.
新型冠状病毒肺炎继发的肺纤维化：吹响战斗的号角？
Lancet Respir Med. 2020 Aug;8(8):750-752. doi: 10.1016/S2213-2600(20)30222-8. Epub 2020 May 15.
4
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.2020 年 2 月至 3 月，意大利佛罗伦萨传染病和热带病科在冠状病毒病（COVID-19）大流行期间的早期经验。
Euro Surveill. 2020 Apr;25(17). doi: 10.2807/1560-7917.ES.2020.25.17.2000556.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
7
Immune regulation by glucocorticoids.糖皮质激素的免疫调节作用。
Nat Rev Immunol. 2017 Apr;17(4):233-247. doi: 10.1038/nri.2017.1. Epub 2017 Feb 13.
8
SARS: systematic review of treatment effects.严重急性呼吸综合征：治疗效果的系统评价
PLoS Med. 2006 Sep;3(9):e343. doi: 10.1371/journal.pmed.0030343.
9
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.皮质类固醇对持续性急性呼吸窘迫综合征的疗效与安全性
N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693.